Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Thulium laser therapy is a safe and effective short-term treatment for hair regrowth.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Trichotillomania was successfully treated with risperidone and naltrexone.

The project developed and tested a method using plasma rich platelets to treat hair loss.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Both intense pulsed light and long-pulsed diode laser effectively reduced facial hair in women, with no significant difference in satisfaction after 6 months, but intense pulsed light was more painful.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Hormone replacement therapy can improve skin aging in postmenopausal women.